Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction

Archives of Surgery

Volumn 134, Issue 12, 1999, Pages 1317-1324

  Lyons, Ann ^a   Goebel, Andreas ^a   Mannick, John A ^a   Lederer, James A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR BLOCKING AGENT; OVALBUMIN; TRINITROPHENYL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0032713325     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.12.1317     Document Type: Article

References (26)

1. Baker CC, Miller CL, Trunkey DD. Predicting fatal sepsis in burn patients. J Trauma. 1979;19:641-648.
2. Esrig BC, Frazee L, Stephenson SF, Polk HCJ, Fulton RL, Jones CE. The predisposition to infection following hemorrhagic shock. Surg Gynecol Obstet. 1977; 144:915-917.
3. Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, Baue AE. Depression of cellular immunity after major injury: its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg. 1986;121:1000-1005.
4. Miller SE, Miller CL, Trunkey DD. The immune consequences of trauma. Surg Clin North Am. 1982;62:167-181.
5. Ninnemann JL, Trauma, sepsis, and the immune response. J Burn Care Rehabil. 1987;8:462-468.
6. Xu YX, Ayala A, Chaudry IH. Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma. 1998;44:335-341.
7. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock. 1999;11:153-159.
8. Moss NM, Gough DB, Jordan AL, et al. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery. 1988;104:882-887.
9. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery. 1996;120:290-296.
10. O'Sullivan ST, Lederer JA, Morgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 1995;222:482-492.
11. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes Nature. 1996;383:787-793.
12. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today. 1992;13:198-200.
13. Kelly JL, Lyons A, Soberg CC, Mannick JA, Lederer JA. Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery. 1997;122:146-152.
14. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg. 1996;131:1303-1308.
15. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg. 1997;226:450-460.
16. O'Riordain MG, Collins KH, Pilz M, Saporoschetz IB, Mannick JA, Rodrick ML. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model Arch Surg. 1992;127:152-158.
17. Molloy RG, Holzheimer R, Nestor M, Collins K, Mannick JA, Rodrick ML. Granulocyte-macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury. Br J Surg. 1995;82:770-776.
18. Gough DB, Moss NM, Jordan A, Grbic JT, Rodrick ML, Mannick JA. Recombinant interleukin-2 (r1L-2) improves immune response and host resistance to septic challenge in thermally injured mice. Surgery. 1988;104:292-300.
19. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin-10 protects mice from lethal endotoxemia. J Exp Med. 1993;177:1205-1208.
20. van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995;155:5397-5401.
21. Lane JS, Todd KE, Lewis MPM, et al. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. Surgery. 1997;122:288-294.
22. Ferrer TJ, Webb JW, Wallace BH, et al. Interleukin-10 reduces morbidity and mortality in murine multiple organ dyslunction syndrome (MODS). J Surg Res. 1998 77:157-164.
23. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 1991;174:1549-1555.
24. Czuprynski CJ, Brown JF, Young KM, Cooley AJ, Kurtz RS. Effects of murine recombinant interleukin-1 alpha on the host response to bacterial infection. J Immunol 1988;140:962-968.
25. Roll JT, Young KM, Kurtz RS, Czuprynski CJ. Human rTNF alpha augments antibacterial resistance in mice: potentiation of its effects by recombinant human IL-1 alpha. Immunology. 1990;69:316-322.
26. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251-276.